- Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid fever vaccine, in the local market
- Vivotif is the only typhoid fever vaccine in Korea that received approval by the U.S. Food and Drug Administration and European Medicines Agency
- In a clinical study of 10,594 patients in Santiago, Chile, where typhoid fever was present, a single dose of Vivotif showed that it prevented typhoid fever in 71 percent of the patients in its first year, and 67 percent of the patients after three years
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Baltimore, MD 21201-1509
Washington, DC 20037
© 2018. Coalition Against Typhoid. All Rights Reserved.